Synthesis 2017; 49(07): 1569-1574
DOI: 10.1055/s-0036-1588369
paper
© Georg Thieme Verlag Stuttgart · New York

Stereoselective Synthesis of a Ceramide Transporter Protein (CERT)-Dependent Ceramide-Trafficking Inhibitor, (1R,3S)-HPA-12, via Gold(I)-Catalyzed Cyclization of a Propargylic N-Hydroxylamine

Authors

  • Bandari Chandrasekhar

    College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-Gu, Seoul 03760, Republic of Korea   Email: ryuj@ewha.ac.kr
  • Sewon Ahn

    College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-Gu, Seoul 03760, Republic of Korea   Email: ryuj@ewha.ac.kr
  • Jae-Sang Ryu*

    College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-Gu, Seoul 03760, Republic of Korea   Email: ryuj@ewha.ac.kr
Further Information

Publication History

Received: 06 October 2016

Accepted after revision: 11 November 2016

Publication Date:
13 December 2016 (online)


Graphical Abstract

Preview

Abstract

A ceramide transporter protein (CERT)-dependent ceramide-trafficking inhibitor, HPA-12, is efficiently synthesized using gold(I)-catalyzed cyclization of a propargylic N-hydroxylamine, which is prepared via a stereoselective nitrone–alkyne addition reaction. The resulting 4-isoxazoline is converted into a syn-1,3-amino alcohol through stereoselective reduction and reductive ring opening.

Supporting Information